There seems to exist a waiting list already.
They are still looking for investment partners.
They are even offering employment to physicians who may qualify for the kind of work they are doing.
Ambrosia Medical, LLC is a California-based company that is betting big on plasma transfusions from young people to older folks as a way to add more years to your life.
What once was a project that started clinical trials two years ago, is now a growing business. Ambrosia is moving to New York in the hopes of attracting rich patients and investors.
The idea of injecting plasma into patients is that of Dr. Jesse Karmazin, the founder and CEO of Ambrosia. Dr. Karmazin is an alumnus of Stanford and Princeton Universities.
On his LinkedIn profile, Karmazin informs contacts that his company is looking forward to raising “$3 million to open the world’s first young plasma infusion center”.
Ambrosia buys plasma, which is not the same as blood. Plasma is a liquid that represents 55% of the blood volume and while in blood, it accompanies red blood cells, white blood cells and platelets, all of which are important in keeping the human body clean and healthy.
In the initial trials, each participant with ages above 35 and who did not have allergies paid around 8,000 euros to receive 1.5 liters of plasma from an unknown person.
Ambrosia guarantees that such plasma comes from blood taken from people with ages between 16 and 25 years.
Neither Ambrosia nor Dr. Karmazin made public the results of such trials. Karmazin simply said that they had been “very positive”.
In a statement published on New Scientist Magazine, Karmazin explains that after the trials “participants had fewer chemical biomarkers indicative of heart disease, Alzheimer’s, and certain types of cancers.”
“Every cell is a factory, pumping out healthy proteins involved in maintaining your body,” says Karmazin. However, later on as our bodies age, that process loses efficiency and the proteins are not produced as well as when people are younger.
Some doctors warn that practices such as the one being carried out by Ambrosia are known to be dangerous, because the human body could react in many different negative ways.
Apparently, according to existing data and the opinion of some scientists, about 50 percent of cases of blood transfusions result in patients suffering from serious side effects.
Physicians say that if the blood that reaches your body does not match yours, it can cause a very strong immune reaction.
It is hard to say whether Ambrosia’s procedure will be damning to patients or not, since the procedure itself is kept secret.
Taking into account that participating in the trial tests already made some people pay eight thousand euros and that the prices will be higher when the clinic opens its doors, it seems.